Ossiam Gilead Sciences, Inc. Transaction History

Ossiam

$5.23 Billion
Q2 2024

A detailed history of Ossiam transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ossiam holds 33,576 shares of GILD stock, worth $2.81 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

33,576

Previous 28,347 18.45%

Holding current value

$2.81 Million

Previous $2.08 Million 10.93%

% of portfolio

0.04%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $330,211 - $381,089	5,229 Added 18.45%	33,576 $2.3 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $765,906 - $934,003	-10,700 Reduced 27.4%	28,347 $2.08 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $399,761 - $453,339	5,456 Added 16.24%	39,047 $3.16 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $5.04 Million - $5.5 Million	-68,222 Reduced 67.01%	33,591 $2.52 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $6.24 Million - $7.12 Million	82,142 Added 417.58%	101,813 $7.85 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $122,459 - $139,518	1,584 Added 8.76%	19,671 $1.63 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $1.48 Million - $2.13 Million	-23,814 Reduced 56.83%	18,087 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $3.8 Million - $4.34 Million	-63,807 Reduced 60.36%	41,901 $2.59 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $9.88 Million - $11.1 Million	-171,170 Reduced 61.82%	105,708 $6.53 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $5.89 Million - $7.38 Million	101,716 Added 58.07%	276,878 $16.5 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $1.15 Million - $1.3 Million	-17,652 Reduced 9.15%	175,162 $12.7 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $4.45 Million - $4.8 Million	-65,728 Reduced 25.42%	192,814 $13.5 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $1.68 Million - $1.84 Million	26,504 Added 11.42%	258,542 $17.7 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $5.42 Million - $6.18 Million	90,343 Added 63.76%	232,038 $15 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $4.05 Million - $4.61 Million	71,444 Added 101.7%	141,695 $8.26 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $60,671 - $76,284	977 Added 1.41%	70,251 $4.44 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $1.7 Million - $1.97 Million	23,456 Added 51.19%	69,274 $5.33 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $2.76 Million - $3.54 Million	44,127 Added 2609.52%	45,818 $3.43 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $85,405 - $93,943	1,386 Added 454.43%	1,691 $110,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $2.55 Million - $2.82 Million	-40,835 Reduced 99.26%	305 $19,000
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $2.55 Million - $2.85 Million	41,140 New	41,140 $2.78 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $13.8 Million - $15.4 Million	-219,960 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $13.3 Million - $17.4 Million	219,960 New	219,960 $13.8 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account